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Mipu1 Inhibits Lipid Accumulation

Introduction
The formation of macrophage-derived foam cells is considered to be the hallmark of atherosclerosis (AS), which is the leading cause of death and illness throughout most of
Western blot analysis
Western blot was carried out with Mipu1 [24] , CD36 and GAPDH (Cell Signaling Technology) antibody [25] according to a previous publication. Electrophoresis and immunoblotting were employed as described previously.
Lipid uptake assay
Two different methods were used to detect the uptake of lipids by macrophages. In the first assay, RAW264.7 cells were washed with PBS for three times after being treatment with oxLDL(The TBARS content was ranging from 5 to 15 nmol MDA/mg cholesterol). Protein content was determined by BCA kit. Proteins were precipitated with 6% trichloroacetic acid, and neutral lipids were extracted with a mixture of hexane/isopropanol (v:v 4:1). The organic phase containing the lipids was collected in a vacuum freeze drying plant at 65℃ and the residues were redissolved in 0.1 lL mixture of isopropanol/n-heptane/ acetonitrile(v:v35:12:52). The mixture was centrifuged at 1500rpm for 5 minutes. Cholesterol ester content was analyzed by high-performance liquid chromatography (HPLC) [26] as described previously (http:// www.ncbi.nlm.nih.gov/pubmed/25141035). For the second method, oxLDL (v/v, 4:1) was labeled with 1,1'-dioctadecyl-3,3,3',3'-tetramethylin docarbocyaninet (Dil) overnight at 37°C. Dil-oxLDL was incubated with RAW264.7 cells for 24 hours at 37 °C, then cells were washed three times with PBS, and then lysed in lysis buffer. The protein concentration was detected by BCA assay. Dil fluorescence was detected following at excitation at 520 nm and emission at 590 nm using a 590 nm cut-off filter (Gemini XS microplate fluorometer). A fluorescence standard curve was prepared by diluting 0, 1, 2, 4, 8, 16 and 32 μg Dil-oxLDL in lysis buffer. Results were normalized to total cell protein concentration.
Plasmids and constructs
A 1500-bp fragment (pGL3-1143) ranging from position −1200 to+299 relative to the transcription start site of the mouse CD36 gene was amplified via PCR using the primers F-1200 (GCCGGTACCTAAGTAACTCGTTCAATATGA) and R+299 (5′-CGGTTCGAATATAGGTAGATCTGTAAATAACA -3′) flanked by KpnI and HindIII restriction sites (restriction sites are in italic) as described before [25] . The amplicons were digested with KpnI and HindIII ligated into the promoterless luciferase reporter plasmid pGL3-Basic (Promega). Other deletion constructs were generated by PCR using the common reverse primer R+299 and the following sense primers (restriction sites are in italic): for construct pGL3-600, 5′-GCCGGTACCTCAGCTAAATTAACAACAA AAAATGA -3′; for construct pGL3-230, 5′-GCCGGTACCGAACATGGCCAAAA AAAAAAAAAAAAGACT -3′. Mutant versions for specific binding sites were prepared by PCR using the common primer pGL3-1200 combined with the following forward primer, which carries a point mutation for MRE-Mut, 5′-CCCATCCAGC AGCACAAGAGGCCAGAGAACCA -3′, and the following reverse primer, 5′-GGC CTCTTGTGCTGCTGGATGGGAACATGGCCA -3′. The sequences of all constructs were confirmed by restriction digestion and direct sequencing.
Transient transfections and luciferase assays
Transient transfections were performed using Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's instructions as described before [25] . Briefly, cells were seeded in a 24-well plate for 24 h before transfection. For each well of cells, 0.8 μg of the CD36 reporter construct was cotransfected with 0.02 μg of pRL-TK vector that provides constitutive expression of Renilla luciferase serving as an internal control. After treatment with oxLDL, cells were harvested, and luciferase activity was measured using a Perkin-Elmer 1420 multilabel counter (USA) according to the instructions of the dual luciferase reporter assay system (Promega). All transfection experiments were carried out in triplicate.
Chromatin immunoprecipitation (ChIP)
ChIP analysis was performed using the EZ ChIP Kit (Upstate, Charlottesville, VA, USA) according to the manufacturer's protocol as described before [25] . Briefly, formaldehyde was added to the culture medium and incubated for 10 min at room temperature. Then, glycine was added to stop fixation, and the cells were scraped and collected. Cell pellets were treated with SDS lysis buffer that contained protease inhibitors. Aliquots of cell lysates were sonicated to shear DNA into 0.2-to 1.0-kb fragments, and cellular debris was removed after centrifugation. The resultant chromatin-containing solutions were aliquotted (100 μl) and stored at −80 °C until use. Chromatin aliquots were precleared with 60 μl of 50% protein G agarose suspension. Samples were then incubated with anti-Mipu1antibody or normal rabbit IgG (Santa Cellular Physiology and Biochemistry
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Cruz iotechnology) overnight at 4 °C with rotation. Immune complexes were mixed with protein G agarose suspension. Beads were collected by brief centrifugation and the immunocomplexes were eluted by freshly prepared elution buffer. Chromatin was then de-crosslinked for 5 h at 65 °C. After treatment with proteinase K, DNA was purified with a QiaQuick PCR purification kit (Qiagen) and finally eluted in 50 μl of Tris EDTA. An aliquot (2 μl) of each sample was subjected to PCR analysis using HotStar Taq DNA polymerase (Qiagen) (32 cycles). The two pairs of primers used to amplify the proximal region of the CD36 promoter that contained the MRE were primers that contained the-237 bp to -244 bp Mipu1 binding site, 5′-CCGTTGGTTCTCTGGCCT CTG-3′ and 5′-AAAGAAAGAGAAGAAAAAAAGTTAAGGG-3′.
Statistical analyses
The results are expressed as mean±SEM. Statistical analyses were performed with the Graphpad Prism V.5 software using the Student's t-test. Significance was taken as p< 0.05. 
The effect of oxLDL on Mipu1 gene expression
The effect of oxLDL on Mipu1 expression was studied using quantitative real-time RT-PCR and western blot. Treatment of RAW264.7 ( Fig. 1A-D) or THP-1( Fig. 1E-H ) cells with oxLDL (75 mg/L) for 24 h resulted in a four-fold increase in Mipu1 mRNA expression compared to controls. Similar increases in Mipu1 protein expression were observed using western blot. The results showed that Mipu1 mRNA and protein expression responsed to oxLDL, but not LDL (Fig. 1 I,J) , with a time and concentration-dependent way (Fig. 1) .
The effect of oxLDL on CD36 mRNA expression and promoter activity
The effect of oxLDL on CD36 mRNA expression and promoter activity was studied using quantitative real-time RT-PCR and luciferase assays. Cells were incubated with oxLDL for various doses and periods of time. mRNA expression of Mipu1 and CD36 was determined by real-time PCR, and luciferase assay was used to detect CD36 promoter activity. As shown in Fig. 2A , B, RAW264.7 cells were incubated with 75 μg/ml oxLDL for various periods of time ranging from 0 to 48 hs. The results showed a sustainable increase of CD36 at both mRNA ( Fig. 2A) and promoter activity in a time-dependent manner (Fig. 2B) . Moreover, at concentrations of 0, 50, 75, and 100 μg/ml, 24-hs oxLDL treatment on RAW264.7 cells led to a significant increase in mRNA levels and promoter activity of CD36 (Fig. 2C and Fig. 2D ).
Identification of a functional MRE in the mouse CD36 promoter
The functional MRE involved in oxLDL responsiveness of the CD36 promoter was next identified. The mouse CD36 promoter contains two potential MREs, residing between −237 and−244 and between−127 and −134, which were termed as MRE-I and MRE-Ⅱ, respectively. To identify the functional MRE(s), mutants of the mouse CD36 promoter were constructed by serially deleting the fragment from−1200 to+299. As shown in Fig. 3B , the deletion from −600 to −230, containing MRE-Ⅱ, showed the most drastically increase to oxLDL. To evaluate further the functional significance of MRE-Ⅱ in the CD36 promoter after oxLDL treatment, site-specific mutations were introduced into MRE-Ⅱ, and oxLDL responsiveness of the mutant construct was determined using transient transfection analysis. Substitutions of four base pairs that flanked MRE-Ⅱ abolished the oxLDL responsiveness of the mutant construct compared to the wild-type construct (Wt MRE-II) (Fig. 3C) . MRE-II is therefore the cis-acting element of the CD36 promoter involved in responses to oxLDL. Direct Mipu1 binding to MRE-II in the CD36 promoter was next determined by measuring occupancy of MRE-II using ChIP assays. oxLDL increased Mipu1 binding to MRE-II of the CD36 promoter (Fig. 3D) .
Mipu1 regulated oxLDL-induced lipid accumulation by modulating CD36 expression in RAW264.7 cells
The development of foam cells containing massive amounts of cholesteryl esters (CE) is a hallmark of AS. CD36 is the most important SR which uptakes oxLDL and contributes to the formation of foam cells [27, 28] . To determine the functional significance of Mipu1 in foam-cell formation, we downregulated expression of endogenous Mipu1 in RAW264.7 cells. HPLC analysis showed that knockdown of Mipu1 has increased cholesteryl esters (CE), total cholesterol (TC) and free cholesterol (FC) levels comparison with control in RAW264.7 cells. 
D, Chromatin immunoprecipitation
(ChIP) was used to show the recruitment of Mipu1 onto the CD36 promoter. Precipitated DNA fragments were analyzed by qPCR using primers flanking the Mipu1 binding site (ACTTAC) in the CD36 promoter. An isotype-matched immunoglobulin G was used as a negative control and 1% input (PCR product of 1/100 of the total isolated DNA used in the ChIP assay) was used as a positive control. *P<0.05.All data represent three independent experiments. IgG, immunoglobulin G. 
Overexpression of CD36 reversed reduction of lipid accumulation in RAW264.7-Mipu1 cells
Our recent data indicated that Mipu1 overexpression attenuated oxLDL-induced lipid accumulation [22] . However, its mechanism is not clear. To further conform whether Mipu1 reduces lipid accumulation through CD36, pIRES -CD36 plasmid was transfected to RAW264.7-Mipu1 cells. HPLC analysis showed that overexpression of CD36 increased CE, TC and FC levels (Fig. 6A) . We also detected the effect of CD36 overexpression on oxLDL uptake by macrophages. As shown in Fig. 6B , CD36 overexpression also induced uptake of oxLDL in macrophages.
Discussion
It was also shown that Mipu1 protein was localized to the nucleus of H9c2 cardiomyocytes and was up-regulated after treatment with H 2 O 2 [20] . Another observation indicated that over-expression of Mipu1 reduced the growth arrest induced by serum withdrawal in C2C12 myogenic cells [18] . These observations indicated that Mipu1 may play a role in maintaining cell homeostasis and protecting the cells from being injured by I/R or oxidative stress. Foam cell formation is a hallmark of the early stages of AS and plays an important role in plaque progression and instability [29] [30] [31] . Increasing evidence has indicated that the foam cells found in the atherosclerotic reaction are macrophages that are derived from blood-borne monocytes or smooth muscle cells. The hallmark of these foam cells is the cholesteryl ester content is over 50% of the total intracellular cholesterol [32, 33] . RAW264.7 macrophages are easy to culture and have strong phagocytic and adhesive abilities, so it has been widely used in studies of the pathways of foam cell formation. In this study, macrophages meet the typical characteristic of foam cells after treatment with 75 mg/L oxLDL for 24 h. Our primary data indicated that Mipu1 overexpression not only decreased uptake of oxLDL, but also synergistically reduced the oxLDL-induced intracellular cholesterol accumulation and inhibited foam-cell formation, and might be associated with modulation of CD36 expression [22] , however the precise mechanism is not clear. In this study, our data showed that oxLDL not only increased Mipu1 expression, but also synergistically induced CD36 mRNA and promoter activity ( Fig. 1 and Fig. 2 ). Increasing evidences suggests that CD36 is an important target for AS treatment [2] , together with our recent results [22] , we hypothesized that Mipu1 may be decrease oxLDL uptake by modulating CD36 expression and/or activity. Indeed, CD36 overexpression rescues lipid accumulation in RAW264.7-Mipu1 cells upon oxLDL (Fig. 3) . It suggested that Mipu1 inhibits the oxLDL-induced lipid accumulation in macrophages via downregulating of CD36 expression. It is proposed that there are also other mechanisms in addition to the downregulation of CD36 expression that are responsible for the cholesterol uptake in presence of oxLDL. We attempted to determine the transcriptional mechanisms of Mipu1 by which oxLDL down-regulated the expression of CD36 gene. We cloned the mouse CD36 promoter and, using the RAW264.7 cells, identified a functional MRE, MRE-Ⅱ(GACTTACT). In our sequencebased analysis of the mouse CD36 promoter using the MatInspector program, there was two potential MRE (MRE-Ⅰ:5′-AGCTTAAC-3′and MRE-Ⅱ: GACTTACT). However, the MRE-Ⅰsite does not seem to be functional because its presence did not significantly affect the oxLDL responsiveness of the CD36 promoter (Fig. 4B) . Deletion of the MRE-II region resulted in significantly increased oxLDL responsiveness of the promoter (Fig. 4B) . Mipu1 induced by oxLDL could bind to MRE-II of the mouse CD36 promoter (Fig. 4D) . Moreover, nucleotide substitutions in the MRE-II region directly affected oxLDL responsiveness of the CD36 promoter compared to Wt MRE-II (Fig. 4C) . These results demonstrated that MRE-II was a functional element for oxLDL-mediated CD36 transcription. A critical functional role for oxLDL-mediated regulation of Mipu1 in the modulation of CD36 expression was further demonstrated in the studies using a siRNA knockdown strategy (Fig. 4) . Interestingly, the reduction in Mipu1 expression by siRNA and the subsequent induction of CD36 levels (Fig.  5) . However, the Mipu1 over-expression in RAW264.7 cells showed only 50% reduction in oxLDL-induced CD36 expression (Fig. 3) . One possible explanation for this observation is that other transcriptional factors, yet unknown, may add to the net capacity of the cells to mediate CD36 expression during oxLDL stimulation.
For mechanism of oxLDL-induced Mipu1expression, We have domosteand specific binding sites for Sp1-family transcription factors on Mipu1 promoter. We also searched transcription-factor-binding sites on the Mipu1 promoter using MatInspector and found some potential-binding sites of stress-response transcription factors, such as HIF alpha, HSF-1, Elk-1, Egr-1, and the GAGA-binding protein [34] . oxLDL can trigger HIF-1alpha accumulation [35] and induced of tissue factor gene expression mediated by both Egr-1 and Sp1 [36] . Thus, further studies are needed to explore the mechanism of Mipu1 up-regulation during oxLDL exposure.
Putting these results in context with the findings of others, we propose that Mipu1 serves as a key protein in macrophages responding to oxLDL stimulation via down-regulating CD36 expression. Our findings are of relevance for the understanding of Mipu1 that contribute to prevention of atherosclerosis.
